Publications by authors named "Charlotte Van Tricht"

Fluorescence in situ hybridization (FISH) is the gold standard for visualizing genomic DNA in fixed cells and tissues, but it is incompatible with live-cell imaging, and its combination with RNA imaging is challenging. Consequently, due to its capacity to bind double-stranded DNA (dsDNA) and design flexibility, the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (CRISPR-Cas9) technology has sparked enormous interest over the past decade. In this review, we describe various nucleic acid (NA)- and protein-based (amplified) signal generation methods that achieve imaging of repetitive and single-copy sequences, and even single-nucleotide variants (SNVs), next to highly multiplexed as well as dynamic imaging in live cells.

View Article and Find Full Text PDF
Article Synopsis
  • Therapeutic drug monitoring (TDM) for adalimumab (ADM) is crucial to maintain treatment effectiveness, but current point-of-care (POC) testing solutions are insufficient.
  • The authors developed a new microfluidic chip that can detect ADM from whole blood within 30 minutes using an easy, self-powered design that separates plasma and performs an ELISA.
  • This technology not only enables TDM at POC but also shows potential for other diagnostic applications, including tests for infectious diseases.
View Article and Find Full Text PDF
Article Synopsis
  • Advanced biological therapies like adalimumab (ADM) are effective but expensive and can lose effectiveness over time; therapeutic drug monitoring (TDM) is suggested to optimize dosing, although it often takes a long time to get results.* -
  • This study introduces a novel ADM-sensor that integrates fiber optic surface plasmon resonance (FO-SPR) and self-powered microfluidics, allowing for quick ADM monitoring directly in a doctor's office.* -
  • The developed biosensor detects ADM in plasma with a limit of detection of 0.35 μg/mL and provides results in under 12 minutes, showcasing significant potential for bedside monitoring of various drugs beyond ADM in the future.*
View Article and Find Full Text PDF